Transaction #27500 · Form 4 · 0000905148-26-000036

Opus Genetics, Inc. · Stock award · Common Stock

Opus Genetics, Inc. · Transacted January 1, 2026 · Filed January 5, 2026

Original SEC filing ↗

What does this filing report?

An SEC Form 4 filing for Opus Genetics, Inc. records a stock award involving Common Stock on January 1, 2026. The reported quantity was 31,188. The filing date is January 5, 2026. This is one transaction record; amounts are not allocated among any joint reporting owners.

The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.

Transaction details

Company CIK
0001228627
Security type
Non-derivative
Acquisition type
Stock award · Code A
Quantity acquired
31,188
Reported price
Not reported · See footnotes
Reference value
Not reported
Currency
Currency not specified
Ownership
Direct
Holdings after transaction
292,951
Ownership description
Not reported
SEC acceptance time
Jan 5, 2026, 4:23 PM EST
10b5-1 indication
Not indicated

Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.

Reporting owners

These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.

Company listings

IRD · Nasdaq · linked security

The linked listing is identified separately from other current company listings.

Filing footnotes & remarks

F1
The Reporting Person was granted shares of common stock in lieu of cash for board services for 2026. The number of shares was determined by dividing (A) the aggregate amount of the retainer to be earned for board services for such period, by (B) the average fair market value of a share of common stock the day prior to the grant date (rounded down to the nearest whole share). The average fair market value was $1.99 per share, the average of the high and low price of the common stock, the day prior to the grant date.

Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.

This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.